David Goeddel Press Articles
Business Wire - Tularik To Webcast Conference Call on First Quarter 2004 Financial Results
Posted by admin / Under David GoeddelApril 20, 2004 -- Business Editors
Business Editors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 20, 2004
Tularik Inc. (Nasdaq: TLRK)...
Business Wire - Tularik to Webcast Conference Call on Full Year 2003 Financial Results
Posted by admin / Under David GoeddelJanuary 21, 2004 -- Business Editors
Business Editors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan. 21, 2004
Tularik Inc. (Nasdaq:TLRK)...
Business Wire - Tularik to Provide Clinical Development Update and 2004 Financial Guidance at JP Morgan Healthcare Conference
Posted by admin / Under David GoeddelJanuary 12, 2004 -- Business Editors/Health/Medical Writers
Business Editors/Health/Medical Writers
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan....
Business Wire - Tularik to Present at the 22nd Annual JPMorgan Healthcare Conference
Posted by admin / Under David GoeddelJanuary 6, 2004 -- Business Editors/Health/Medical Writers
Business Editors/Health/Medical Writers
JPMorgan 22nd Annual Healthcare Conference
...
Business Wire - Tularik Earns Milestone Payment from Eli Lilly and Company; Oral Factor Xa Inhibitor Enters Phase 2 Study for the Treatment of Thrombotic Diseases
Posted by admin / Under David GoeddelDecember 4, 2003 -- Business Editors/Health/Medical Writers
Business Editors/Health/Medical Writers
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec. 4,...
